Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels

Brain Research

Volumn 721, Issue 1-2, 1996, Pages 126-131

  Welch, Catherine C ^a   Kim, Eun Mee ^b   Grace, Martha K ^a   Billington, Charles J ^a,b   Levine, Allen S ^a,b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Fat; Highly palatable diet; Opioid; Opioid mRNA; Opioid peptide; Sucrose

Indexed keywords

BETA ENDORPHIN; DYNORPHIN; DYNORPHIN A; MESSENGER RNA; METENKEPHALIN; PRODYNORPHIN; PROENKEPHALIN; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; CONTROLLED STUDY; FAT INTAKE; FEEDING BEHAVIOR; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029980049     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00151-5     Document Type: Article

References (39)

1. Apfelbaum, M. and Mandenoff, A., Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet, Pharmacol. Biochem. Behav., 15 (1981) 89-91.
2. Arjune, D. and Bodnar, R.J., Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphimine, Brain Res., 534 (1990) 313-316.
3. Baile, C.A., McLaughlin, C.L. and Della-Fera, M.A., Role of cholecystokinin and opioid peptides in control of food intake, Physiol. Rev., 66 (1986) 172-234.
4. Beczkowska, I.W., Bowen, W.D. and Bodnar, R.J., Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res., 589 (1992) 291-301.
5. Bertino, M., Beauchamp, G.K. and Engelman, K., Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans, Am. J. Physiol., 261 (1991) R59-63.
6. Brennan, G., Bachus, S.E. and Jhanwar-Uniyal, M., Involvement of gene expression for hypothalamic dynorphin in dietary preference, J. Neurosci., 20 (1994) 818 (Abstract).
7. Calcagnetti, D.J., Calcagnetti, R.L. and Fanselow, M.S., Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solution, Pharmacol. Biochem. Behav., 35 (1990) 69-73.
8. Calcagnetti, D.J. and Reid, L.D., Morphine and acceptability of putative reinforcers, Pharmacol. Biochem. Behav., 18 (1983) 567-569.
9. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
10. Cooper, S.J., Barber, D.J. and Barbour-McMullen, J., Selective attenuation of sweetened milk consumption by opiate receptor antagonists in male and female rats of the Roman strains, Neuropeptides, 5 (1985) 349-52.
11. Cooper, S.J., Jackson, A., Morgan, R. and Carter, R., Evidence for opiate receptor involvement in the consumption of a high palatability diet in nondeprived rats, Neuropeptides, 5 (1985) 345-8.
12. Drewnowski, A., Krahn, D.D., Demitrack, M.A., Nairn, K. and Gosnell, B.A., Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement, Physiol. Behav., 51 (1992) 371-9.
13. Dum, J., Gramsch, C. and Herz, A., Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable food, Pharmacol. Biochem. Behav., 18 (1983) 443-7.
14. Fantino, M., Hosotte, J. and Apfelbaum, M., An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am. J. Physiol., 251 (1986) R91-6.
15. Giraudo, S.Q., Grace, M.K., Welch, C.C., Billington, C.J. and Levine, A.S., Naloxone's anorectic effect is dependent upon the relative palatability of food, Pharmacol. Biochem. Behav., 46 (1993) 917-921.
16. Gosnell, B.A. and Majchrzak, M.J., Centrally administered opioid peptides stimulate saccharin intake in nondeprived rats, Pharmacol. Biochem. Behav., 33 (1989) 805-810.
17. Gunion, M.W. and Peters, R.H., Pituitary beta-endorphin, naloxone, and feeding in several experimental obesities, Am. J. Physiol., 241 (1981) R173-84.
18. Jackson, A. and Cooper, S.J., Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads, Brain Res. Bull., 15 (1985) 391-6.
19. Kim, E-M., Welch, C.C., Grace, M.K., Billington, C.J. and Levine, A.S., Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus, Am. J. Physiol., in press.
20. Kirkham, T.C. and Cooper, S.J., Attenuation of sham feeding by naloxone is stereospecific: evidence for opioid mediation of orosensory reward, Physiol. Behav., 43 (1988) 845-7.
21. Leventhal, L., Kirkham, T.C., Cole, J.L. and Bodnar, R.J., Selective actions of central μ and k opioid antagonists upon sucrose intake in sham-fed rats., Brain Res., 685 (1995) 205-210.
22. Levine, A.S., Murray, S.S., Kneip, J., Grace, M. and Morley, J.E., Flavor enhances the antidipsogenic effect of naloxone, Physiol. Behav., 28 (1982) 23-25.
23. Levine, A.S., Weldon, D.T., Grace, M., Cleary, J.P. and Billington, C.J., Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am. J. Physiol., 268 (1995) R248-R252.
24. Lynch, W.C., Opiate blockade inhibits saccharin intake and blocks normal preference acquisition, Pharmacol. Biochem. Behav., 24 (1986) 833-836.
25. Lynch, W.C. and Libby, L., Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated rats, Life Sci., 33 (1983) 1909-14.
26. Margules, D.L., Moisset, B., Lewis, M.J., Shibuya, H. and Pert, C.B., beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa), Science, 202 (1978) 988-91.
27. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, 1986.
28. Przewlocki, R., Lason, W., Konecka, A.M., Gramsch, C., Herz, A. and Reid, L.D., The opioid peptide dynorphin, circadian rhythms, and starvation, Science, 219 (1983) 71-73.
29. Recant, L., Voyles, N.R., Luciano, M. and Pert, C.B., Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice, Peptides, 1 (1980) 309-13.
30. Reid, L.D., Endogenous opioid peptides and regulation of drinking and feeding., Am. J. Clin. Nutr., 42 (1985) 1099-132.
31. Robert, J.J., Orosco, M., Rouch, C., Jacquot, C. and Cohen, Y., Effects of opiate agonists and an antagonist on food intake and brain neurotransmitters in normophagic and obese "cafeteria" rats, Pharmacol. Biochem. Behav., 34 (1989) 577-83.
32. Romsos, D.R., Gosnell, B.A., Morley, J.E. and Levine, A.S., Effects of kappa opiate agonists, cholecystokinin and bombesin on intake of diets varying in carbohydrate-to-fat ratio in rats, J. Nutr., 117 (1987) 976-85.
33. Takahashi, H., Motomatsu, T., Nawata, H., Kato, K., Ibayashi, H. and Nobunaga, M., Influences of feeding and drinking on circadian rhythms of opioid peptides in plasma, hypothalamus and pituitary gland in rats, Physiol. Behav., 37 (1986) 609-614.
34. Thurston, S.J. and Safler, J.D., Blot shadowing procedure, Red Book Bull. Curr. Protocols Mol. Biol., 10 (1990) 1.
35. Yeomans, M.R., Prior exposure to low or high fat milk enhances naloxone anorexia in rats, Appetite, 20 (1993) 125-134.
36. Yeomans, M.R. and Wright, P., Lower pleasantness of palatable foods in nalmefene-treated human volunteers, Appetite, 16 (1991) 249-59.
37. Yeomans, M.R., Wright, P., Macleod, H.A. and Critchley, J.A., Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability, Psychopharmacology, 100 (1990) 426-32.
38. Yirmiya, R., Lieblich, I. and Liebeskind, J.C., Reduced saccharin preference in CXBK (opioid receptor-deficient) mice, Brain Res., 438 (1988) 339-42.
39. Zhang, T. and Rockhold, R.W., Sucrose drinking reduces dorsal hypothalamic β-endorphin levels in spontaneously hypertensive rats but not in Wistar-Kyoto rats, Brain Res. Bull., 32 (1993) 261-265.